India  

Inching towards WHO's emergency use approval for Covaxin: Bharat Biotech

IndiaTimes Wednesday, 30 June 2021
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Covaxin Covaxin Vaccine against COVID-19

Covaxin supply to hit 5.5 cr doses from October: Bharat Biotech chairman

Covaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr..
IndiaTimes

Covaxin may soon get WHO approval as expert group scheduled to meet next month

SAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.
DNA
Mixing vaccines study gets DCGI nod | Are 2 different vaccines better than 1? | Oneindia News [Video]

Mixing vaccines study gets DCGI nod | Are 2 different vaccines better than 1? | Oneindia News

A study on mixing Covishield and Covaxin has been given the go ahead by the drug regulator--Drug Controller General of India. This study and its clinical trials will be conducted by Vellore's Christian Medical College. #MixingVaccines #VaccineCocktail #ICMR

Credit: Oneindia    Duration: 01:46Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer


Related videos from verified sources

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News [Video]

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News

Bharat Biotech has submitted Phase 3 clinical trial data for its Covid-19 vaccine, Covaxin, to the Drug Controller General of India (DCGI). The development comes nearly five months after Covaxin was..

Credit: Oneindia     Duration: 02:02Published

Related news from verified sources

No emergency use, US FDA asks Bharat Biotech to obtain full approval


Indian Express

Covid-19: WHO accepts expression of interest for Covaxin emergency use listing

Covaxin has inched a step closer to a World Health Organization (WHO) emergency use listing (EUL) with the global body accepting Bharat Biotech’s expression of...
IndiaTimes

Vir Das, Konkona raise concern after Covaxin was denied approval in the US

Vir Das, Konkona raise concern after Covaxin was denied approval in the US
The US Food and Drug Administration has denied approval for emergency use of Covaxin, developed by Hyderabad-based Bharat Biotech, and has asked for additional...
Mid-Day Also reported by •IndiaTimes